Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4781144 | 0.82 | CYP3A4 (0.46) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL7602983 | 0.82 | LMNA (0.46) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL23031992 | 0.82 | ALDH1A1 (0.44) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL7867200 | 0.81 | CYP3A4 (0.61) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL6638391 | 0.79 | LMNA (0.47) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL9547533 | 0.79 | NPSR1 (0.46) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL11224647 | 0.78 | ALDH1A1 (0.46) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL7601412 | 0.78 | ALDH1A1 (0.44) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL9175691 | 0.78 | ALDH1A1 (0.44) | LMNAALDH1A1KDM4ECYP3A4TRPM8 | |
| SCHEMBL8779541 | 0.77 | TRPM8 (0.51) | LMNAALDH1A1CYP3A4TRPM8TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116547266-A | Synthesis method of anthranilic acid/amide compound and intermediate thereof | 皮埃企业有限公司 | 2023-08-04 | — | — | CN | disclosed |
| US-20210054007-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2021-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210054007-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | LMNA 4605/4885ALDH1A1 1113/4885KDM4E 3486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.